Role of fixed combinations in the management of open-angle glaucoma. - Wikidata - wikimedia - TriplyDB

Role of fixed combinations in the management of open-angle glaucoma.

Role of fixed combinations in the management of open-angle glaucoma.

http://www.wikidata.org/entity/Q37847155

about

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.Bimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece.How ocular surface disease impacts the glaucoma treatment outcome Nonclinical Development of Combination Drugs.Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

P2860

Q26830201-9E0750C2-4AE3-4270-B753-412A0C193914 Q34253481-EED826E4-B75A-438B-952A-A4E05FE1E3A0 Q36622405-2200BC60-7C3B-47BA-992D-B9D5B1001AF2 Q37259818-02347ADA-6F29-4594-88B7-E2447E76B756 Q38658447-10F4B219-F9B6-4297-878F-70C77735A178 Q42703310-520806F5-C956-4570-8B6F-6D9A1C99D889 Q47381165-7616A365-D6B5-447A-AA28-AC3EC6988C0B

P2860

Role of fixed combinations in the management of open-angle glaucoma.

http://www.wikidata.org/entity/Q37847155

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of fixed combinations in the management of open-angle glaucoma.

@en

Role of fixed combinations in the management of open-angle glaucoma.

@nl

type

label

Role of fixed combinations in the management of open-angle glaucoma.

@en

Role of fixed combinations in the management of open-angle glaucoma.

@nl

prefLabel

Role of fixed combinations in the management of open-angle glaucoma.

@en

Role of fixed combinations in the management of open-angle glaucoma.

@nl

P1433

Q37847155-47194ED8-9265-4388-AFB8-270250AC28F0

P1476

Q37847155-7AF4F1D0-59AF-4369-83C7-DB725FAE9CF0

P2093

Q37847155-FB9EA4CB-05C4-4D78-BB57-FE52A39EF501

P2860

Q37847155-03706034-491C-4C8E-AA2E-2C825AC31AF5

Q37847155-050587B2-F5F0-41AE-8302-731B7D17EB70

Q37847155-053071A2-EA45-45DF-967C-2F1317BB3C93

Q37847155-05C57B0F-6447-4BC2-B3C9-C536F2FCCBBF

Q37847155-1277B9FC-EDA1-445D-B89B-EB2EE411DCB6

Q37847155-173E8435-A305-4923-A754-BD89EE928027

Q37847155-23A8DDF7-90D3-4BC5-9A84-C94202D226B6

Q37847155-2B54200A-93C9-4B2E-A341-B5FD52E036B4

Q37847155-2E3C1DA2-50ED-4A26-AA4A-48A8AA17AD7A

Q37847155-30762B96-0139-49E7-A4F3-DBB671DD1D69

P304

Q37847155-0638A848-F14B-4C24-8DB4-14A2AEA90F2C

P31

Q37847155-126B4ED3-4D07-4595-AD1C-36E31B1833BD

P356

Q37847155-62F8FF1A-33A9-4FF6-9620-AFCBF6D91279

P433

Q37847155-ACA18603-101A-4917-B931-5A1B2213B64F

P478

Q37847155-C07C6DF0-3198-45F0-B540-CEC384D60A34

P577

Q37847155-9E82F712-B9E7-44E0-913A-09EEAAAD7C31

P698

Q37847155-D788C28B-8631-46DD-BA59-ED08FAC99F56

P356

P1433

Expert Review of Pharmacoeconomics & Outcomes Research

P1476

Role of fixed combinations in the management of open-angle glaucoma.

@en

P2093

Anton Hommer

http://www.w3.org/2001/XMLSchema#string

P2860

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Clinical outcomes of glaucoma treatments over a patient lifetime: a Markov model.

Use of fixed-dose combination drugs for the treatment of glaucoma.

Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.

Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

Intraocular pressure measurements throughout the 24 h.

The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

P304

91-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERP.10.83

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21351861

http://www.w3.org/2001/XMLSchema#string